Author + information
- Bertram Pitt, MD, FACC*,
- Victor Kaiff, MB,
- Mark A. Rabinovitch, MD,
- Andrew J. Buda, MD, FACC,
- Harry T. Colfer, MD,
- Robert A. Vogel, MD and
- James H. Thrall, MD
- ↵*Address for reprints: Bertram Pitt, MD, Division of Cardiology and Nuclear Medicine, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan 48109.
Radiotracer studies of the heart have become clinically important in the last decade, especially for evaluation of patients with known or suspected ischemic heart disease. Radionuclide ventriculography provides quantitative measures of biventricular function and regional wall motion. Recent technical advances include the development of computer programs for analyzing diastolic function, parametric imaging methods such as "phase" analysis and methods for calculating absolute ventricular volumes.
Thallium-201 scans provide maps of regional myocardial perfusion. Recent advances include development of computer programs to quantitate regional thallium-201 uptake and to calculate thallium-201 turnover rates and the development of tomographic imaging systems.
Technetium-99m pyrophosphate localizes in irreversibly damaged myocardium and provides a method for diagnosing, localizing and sizing acute myocardial infarcts. Recent applications include tomographic imaging to improve image contrast and development of criteria to identify high risk patients after infarction.
Two important trends affecting the application of all the radionuclide studies in clinical cardiologic practice are the increasing use of decision analysis for incorporating results of multiple tests into single diagnostic probability statements, and the use of diagnostic algorithms that include the radionuclide studies to optimize the cost effectiveness of evaluation of patients with ischemic heart disease.
- American College of Cardiology Foundation